Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tissue Regenix Group PLC (GB:TRX)
LSE:TRX
Holding GB:TRX?
Track your performance easily
TRX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range50.00p - 75.00p
Previous Close61p
Volume22.38K
Average Volume (3M)51.31K
Market Cap
£43.45M
Enterprise Value45.59M
Total Cash (Recent Filing)$5.95M
Total Debt (Recent Filing)$9.61M
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Jun 05, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding70,574,468
10 Day Avg. Volume54,102
30 Day Avg. Volume51,306
Standard Deviation0.21
R-Squared0.16
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)141.86
Price to Sales (P/S)2.11
Price to Cash Flow (P/CF)-40.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.86
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Tissue Regenix News
PremiumCompany Announcements
Tissue Regenix Celebrates Sustained Growth in H1 2024
PremiumCompany Announcements
Tissue Regenix Announces Upcoming Interim Results
PremiumCompany Announcements
Tissue Regenix Executives Receive Stock OptionsPremiumCompany Announcements
Tissue Regenix Continues Profitable Growth Streak
PremiumCompany Announcements
Tissue Regenix Investor Stake Change Notable
PremiumCompany Announcements
Tissue Regenix Reports Major Stake Change
PremiumCompany Announcements
Tissue Regenix Issues New Shares Post-Options ExercisePremiumCompany Announcements
Tissue Regenix Bolsters Expansion with Smart AcquisitionTRX FAQ
What was Tissue Regenix Group PLC’s price range in the past 12 months?
Tissue Regenix Group PLC lowest share price was 50.00p and its highest was 75.00p in the past 12 months.
What is Tissue Regenix Group PLC’s market cap?
Currently, no data Available
When is Tissue Regenix Group PLC’s upcoming earnings report date?
Tissue Regenix Group PLC’s upcoming earnings report date is Jun 05, 2025 which is in 258 days.
How were Tissue Regenix Group PLC’s earnings last quarter?
Tissue Regenix Group PLC released its earnings results on Sep 10, 2024. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
Is Tissue Regenix Group PLC overvalued?
According to Wall Street analysts Tissue Regenix Group PLC’s price is currently Overvalued.
Does Tissue Regenix Group PLC pay dividends?
Tissue Regenix Group PLC does not currently pay dividends.
What is Tissue Regenix Group PLC’s EPS estimate?
Tissue Regenix Group PLC’s EPS estimate is £0.
How many shares outstanding does Tissue Regenix Group PLC have?
Tissue Regenix Group PLC has 71,395,640 shares outstanding.
What happened to Tissue Regenix Group PLC’s price movement after its last earnings report?
Tissue Regenix Group PLC reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Tissue Regenix Group PLC?
Currently, no hedge funds are holding shares in GB:TRX
---
Tissue Regenix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth £129.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.96%
12-Months-Change
Fundamentals
Return on Equity
-3.66%
Trailing 12-Months
Asset Growth
0.99%
Trailing 12-Months
Company Description
Tissue Regenix Group PLC
Tissue Regenix Group PLC is a player in the field of biotechnology. It is a medical technology company engaged in the development of regenerative products. The company incorporates dcell technology, which helps to address complex and varying clinical needs. The company has operations worldwide, with special emphasis in the United States.
---
Technical Analysis
Advanced Medical Solutions
―
Creo Medical
―
EKF Diagnostics Holdings
―
PureTech Health
―
---